Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04201145
Title Pembrolizumab + Defactinib In Pleural Mesothelioma
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Raphael Bueno, MD
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Brigham and Women's Hospital Boston Massachusetts 02115 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field